Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Cancer Immunotherapy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
PD-1 Inhibitor Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapy Drug include Autolus Therapeutics plc, BeiGene, bluebird bio, Inc., Bristol-Myers Squibb, Celgene Corporation, AstraZeneca plc, Gilead Sciences, Inc., Incyte Corporation and Jiangsu Hengrui Medicine, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Immunotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Immunotherapy Drug. This report contains market size and forecasts of Cancer Immunotherapy Drug in global, including the following market information:
Global Cancer Immunotherapy Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Immunotherapy Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Immunotherapy Drug companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Immunotherapy Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapy Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Immunotherapy Drug Market Segment Percentages, by Type, 2022 (%)
PD-1 Inhibitor
PDL-1 Inhibitor
T-Cell Stimulant
CTLA Antibody
Global Cancer Immunotherapy Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Immunotherapy Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Cancer Immunotherapy Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Immunotherapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Immunotherapy Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Immunotherapy Drug revenues share in global market, 2022 (%)
Key companies Cancer Immunotherapy Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Immunotherapy Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Autolus Therapeutics plc
BeiGene
bluebird bio, Inc.
Bristol-Myers Squibb
Celgene Corporation
AstraZeneca plc
Gilead Sciences, Inc.
Incyte Corporation
Jiangsu Hengrui Medicine
Juno Pharmaceuticals Pty Ltd.
Medimmune, LLC
Merck & Co., Inc.
Novartis AG
Pfizer, Inc.
Roche Holding AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Immunotherapy Drug, market overview.
Chapter 2: Global Cancer Immunotherapy Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Immunotherapy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Immunotherapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Immunotherapy Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Cancer Immunotherapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Immunotherapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Immunotherapy Drug Overall Market Size
2.1 Global Cancer Immunotherapy Drug Market Size: 2022 VS 2029
2.2 Global Cancer Immunotherapy Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cancer Immunotherapy Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Cancer Immunotherapy Drug Players in Global Market
3.2 Top Global Cancer Immunotherapy Drug Companies Ranked by Revenue
3.3 Global Cancer Immunotherapy Drug Revenue by Companies
3.4 Global Cancer Immunotherapy Drug Sales by Companies
3.5 Global Cancer Immunotherapy Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Immunotherapy Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Immunotherapy Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Immunotherapy Drug Players in Global Market
3.8.1 List of Global Tier 1 Cancer Immunotherapy Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Immunotherapy Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Immunotherapy Drug Market Size Markets, 2022 & 2029
4.1.2 PD-1 Inhibitor
4.1.3 PDL-1 Inhibitor
4.1.4 T-Cell Stimulant
4.1.5 CTLA Antibody
4.2 By Type - Global Cancer Immunotherapy Drug Revenue & Forecasts
4.2.1 By Type - Global Cancer Immunotherapy Drug Revenue, 2018-2023
4.2.2 By Type - Global Cancer Immunotherapy Drug Revenue, 2024-2029
4.2.3 By Type - Global Cancer Immunotherapy Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Cancer Immunotherapy Drug Sales & Forecasts
4.3.1 By Type - Global Cancer Immunotherapy Drug Sales, 2018-2023
4.3.2 By Type - Global Cancer Immunotherapy Drug Sales, 2024-2029
4.3.3 By Type - Global Cancer Immunotherapy Drug Sales Market Share, 2018-2029
4.4 By Type - Global Cancer Immunotherapy Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Immunotherapy Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Cancer Immunotherapy Drug Revenue & Forecasts
5.2.1 By Application - Global Cancer Immunotherapy Drug Revenue, 2018-2023
5.2.2 By Application - Global Cancer Immunotherapy Drug Revenue, 2024-2029
5.2.3 By Application - Global Cancer Immunotherapy Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Cancer Immunotherapy Drug Sales & Forecasts
5.3.1 By Application - Global Cancer Immunotherapy Drug Sales, 2018-2023
5.3.2 By Application - Global Cancer Immunotherapy Drug Sales, 2024-2029
5.3.3 By Application - Global Cancer Immunotherapy Drug Sales Market Share, 2018-2029
5.4 By Application - Global Cancer Immunotherapy Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Immunotherapy Drug Market Size, 2022 & 2029
6.2 By Region - Global Cancer Immunotherapy Drug Revenue & Forecasts
6.2.1 By Region - Global Cancer Immunotherapy Drug Revenue, 2018-2023
6.2.2 By Region - Global Cancer Immunotherapy Drug Revenue, 2024-2029
6.2.3 By Region - Global Cancer Immunotherapy Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Cancer Immunotherapy Drug Sales & Forecasts
6.3.1 By Region - Global Cancer Immunotherapy Drug Sales, 2018-2023
6.3.2 By Region - Global Cancer Immunotherapy Drug Sales, 2024-2029
6.3.3 By Region - Global Cancer Immunotherapy Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Cancer Immunotherapy Drug Revenue, 2018-2029
6.4.2 By Country - North America Cancer Immunotherapy Drug Sales, 2018-2029
6.4.3 US Cancer Immunotherapy Drug Market Size, 2018-2029
6.4.4 Canada Cancer Immunotherapy Drug Market Size, 2018-2029
6.4.5 Mexico Cancer Immunotherapy Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Cancer Immunotherapy Drug Revenue, 2018-2029
6.5.2 By Country - Europe Cancer Immunotherapy Drug Sales, 2018-2029
6.5.3 Germany Cancer Immunotherapy Drug Market Size, 2018-2029
6.5.4 France Cancer Immunotherapy Drug Market Size, 2018-2029
6.5.5 U.K. Cancer Immunotherapy Drug Market Size, 2018-2029
6.5.6 Italy Cancer Immunotherapy Drug Market Size, 2018-2029
6.5.7 Russia Cancer Immunotherapy Drug Market Size, 2018-2029
6.5.8 Nordic Countries Cancer Immunotherapy Drug Market Size, 2018-2029
6.5.9 Benelux Cancer Immunotherapy Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Cancer Immunotherapy Drug Revenue, 2018-2029
6.6.2 By Region - Asia Cancer Immunotherapy Drug Sales, 2018-2029
6.6.3 China Cancer Immunotherapy Drug Market Size, 2018-2029
6.6.4 Japan Cancer Immunotherapy Drug Market Size, 2018-2029
6.6.5 South Korea Cancer Immunotherapy Drug Market Size, 2018-2029
6.6.6 Southeast Asia Cancer Immunotherapy Drug Market Size, 2018-2029
6.6.7 India Cancer Immunotherapy Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Cancer Immunotherapy Drug Revenue, 2018-2029
6.7.2 By Country - South America Cancer Immunotherapy Drug Sales, 2018-2029
6.7.3 Brazil Cancer Immunotherapy Drug Market Size, 2018-2029
6.7.4 Argentina Cancer Immunotherapy Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Immunotherapy Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Cancer Immunotherapy Drug Sales, 2018-2029
6.8.3 Turkey Cancer Immunotherapy Drug Market Size, 2018-2029
6.8.4 Israel Cancer Immunotherapy Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Cancer Immunotherapy Drug Market Size, 2018-2029
6.8.6 UAE Cancer Immunotherapy Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Autolus Therapeutics plc
7.1.1 Autolus Therapeutics plc Company Summary
7.1.2 Autolus Therapeutics plc Business Overview
7.1.3 Autolus Therapeutics plc Cancer Immunotherapy Drug Major Product Offerings
7.1.4 Autolus Therapeutics plc Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.1.5 Autolus Therapeutics plc Key News & Latest Developments
7.2 BeiGene
7.2.1 BeiGene Company Summary
7.2.2 BeiGene Business Overview
7.2.3 BeiGene Cancer Immunotherapy Drug Major Product Offerings
7.2.4 BeiGene Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.2.5 BeiGene Key News & Latest Developments
7.3 bluebird bio, Inc.
7.3.1 bluebird bio, Inc. Company Summary
7.3.2 bluebird bio, Inc. Business Overview
7.3.3 bluebird bio, Inc. Cancer Immunotherapy Drug Major Product Offerings
7.3.4 bluebird bio, Inc. Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.3.5 bluebird bio, Inc. Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Cancer Immunotherapy Drug Major Product Offerings
7.4.4 Bristol-Myers Squibb Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation Cancer Immunotherapy Drug Major Product Offerings
7.5.4 Celgene Corporation Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 AstraZeneca plc
7.6.1 AstraZeneca plc Company Summary
7.6.2 AstraZeneca plc Business Overview
7.6.3 AstraZeneca plc Cancer Immunotherapy Drug Major Product Offerings
7.6.4 AstraZeneca plc Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca plc Key News & Latest Developments
7.7 Gilead Sciences, Inc.
7.7.1 Gilead Sciences, Inc. Company Summary
7.7.2 Gilead Sciences, Inc. Business Overview
7.7.3 Gilead Sciences, Inc. Cancer Immunotherapy Drug Major Product Offerings
7.7.4 Gilead Sciences, Inc. Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.7.5 Gilead Sciences, Inc. Key News & Latest Developments
7.8 Incyte Corporation
7.8.1 Incyte Corporation Company Summary
7.8.2 Incyte Corporation Business Overview
7.8.3 Incyte Corporation Cancer Immunotherapy Drug Major Product Offerings
7.8.4 Incyte Corporation Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.8.5 Incyte Corporation Key News & Latest Developments
7.9 Jiangsu Hengrui Medicine
7.9.1 Jiangsu Hengrui Medicine Company Summary
7.9.2 Jiangsu Hengrui Medicine Business Overview
7.9.3 Jiangsu Hengrui Medicine Cancer Immunotherapy Drug Major Product Offerings
7.9.4 Jiangsu Hengrui Medicine Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.9.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.10 Juno Pharmaceuticals Pty Ltd.
7.10.1 Juno Pharmaceuticals Pty Ltd. Company Summary
7.10.2 Juno Pharmaceuticals Pty Ltd. Business Overview
7.10.3 Juno Pharmaceuticals Pty Ltd. Cancer Immunotherapy Drug Major Product Offerings
7.10.4 Juno Pharmaceuticals Pty Ltd. Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.10.5 Juno Pharmaceuticals Pty Ltd. Key News & Latest Developments
7.11 Medimmune, LLC
7.11.1 Medimmune, LLC Company Summary
7.11.2 Medimmune, LLC Cancer Immunotherapy Drug Business Overview
7.11.3 Medimmune, LLC Cancer Immunotherapy Drug Major Product Offerings
7.11.4 Medimmune, LLC Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.11.5 Medimmune, LLC Key News & Latest Developments
7.12 Merck & Co., Inc.
7.12.1 Merck & Co., Inc. Company Summary
7.12.2 Merck & Co., Inc. Cancer Immunotherapy Drug Business Overview
7.12.3 Merck & Co., Inc. Cancer Immunotherapy Drug Major Product Offerings
7.12.4 Merck & Co., Inc. Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.12.5 Merck & Co., Inc. Key News & Latest Developments
7.13 Novartis AG
7.13.1 Novartis AG Company Summary
7.13.2 Novartis AG Cancer Immunotherapy Drug Business Overview
7.13.3 Novartis AG Cancer Immunotherapy Drug Major Product Offerings
7.13.4 Novartis AG Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.13.5 Novartis AG Key News & Latest Developments
7.14 Pfizer, Inc.
7.14.1 Pfizer, Inc. Company Summary
7.14.2 Pfizer, Inc. Business Overview
7.14.3 Pfizer, Inc. Cancer Immunotherapy Drug Major Product Offerings
7.14.4 Pfizer, Inc. Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.14.5 Pfizer, Inc. Key News & Latest Developments
7.15 Roche Holding AG
7.15.1 Roche Holding AG Company Summary
7.15.2 Roche Holding AG Business Overview
7.15.3 Roche Holding AG Cancer Immunotherapy Drug Major Product Offerings
7.15.4 Roche Holding AG Cancer Immunotherapy Drug Sales and Revenue in Global (2018-2023)
7.15.5 Roche Holding AG Key News & Latest Developments
8 Global Cancer Immunotherapy Drug Production Capacity, Analysis
8.1 Global Cancer Immunotherapy Drug Production Capacity, 2018-2029
8.2 Cancer Immunotherapy Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Immunotherapy Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Immunotherapy Drug Supply Chain Analysis
10.1 Cancer Immunotherapy Drug Industry Value Chain
10.2 Cancer Immunotherapy Drug Upstream Market
10.3 Cancer Immunotherapy Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Immunotherapy Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
